These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11880967)

  • 21. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
    Dheda K; Lampe FC; Johnson MA; Lipman MC
    J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance characteristics of Mycobacterium tuberculosis isolates to four first-line antituberculous drugs from tuberculosis patients with AIDS in Beijing, China.
    Gao GJ; Lian L; Sun Y; Wei J; Xiao J; Wang X; Zhang L; Zhao X; Yang D; Zhao HX; Zhao H; Wang HZ; Wan KL; Li XW
    Int J Antimicrob Agents; 2015 Feb; 45(2):124-9. PubMed ID: 25459740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The experience of patients living with human-immunodeficiency virus/tuberculosis co-infection: a systematic review of qualitative evidence protocol.
    Protti S; Evans C; Nalubega S
    JBI Database System Rev Implement Rep; 2015 Aug; 13(7):72-82. PubMed ID: 26455847
    [No Abstract]   [Full Text] [Related]  

  • 25. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
    Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
    Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the levels of oxidative stress parameters in HIV and HIV-TB co-infected patients.
    Awodele O; Olayemi SO; Nwite JA; Adeyemo TA
    J Infect Dev Ctries; 2012 Jan; 6(1):79-85. PubMed ID: 22240433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
    El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
    Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
    J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection.
    Coggin WL; Ryan CA; Holmes CB
    Clin Infect Dis; 2010 May; 50 Suppl 3():S255-9. PubMed ID: 20397956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.
    Mugusi SF; Ngaimisi E; Janabi MY; Mugusi FM; Minzi OM; Sasi PG; Bakari M; Lindquist L; Aklillu E; Sandstrom EG
    Antivir Ther; 2012; 17(2):265-74. PubMed ID: 22293579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.
    Flament-Saillour M; Robert J; Jarlier V; Grosset J
    Am J Respir Crit Care Med; 1999 Aug; 160(2):587-93. PubMed ID: 10430733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV infection-associated tuberculosis: the epidemiology and the response.
    Getahun H; Gunneberg C; Granich R; Nunn P
    Clin Infect Dis; 2010 May; 50 Suppl 3():S201-7. PubMed ID: 20397949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
    Angarano G; Carbonara S; Costa D; Gori A
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan.
    Tseng SH; Jiang DD; Hoi HS; Yang SL; Hwang KP
    Am J Trop Med Hyg; 2009 Apr; 80(4):675-7. PubMed ID: 19346398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis with human immunodeficiency virus infection.
    Cherian T; Verghese VP
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S47-52. PubMed ID: 11129908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.
    Velasco M; Castilla V; Sanz J; Gaspar G; Condes E; Barros C; Cervero M; Torres R; Guijarro C;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):148-52. PubMed ID: 19131895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
    Kwara A; Carter EJ; Rich JD; Flanigan TP
    AIDS Patient Care STDS; 2004 Jun; 18(6):341-7. PubMed ID: 15294084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.